Literature DB >> 18227523

Is anemia of cancer different from chemotherapy-induced anemia?

David P Steensma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18227523     DOI： 10.1200/JCO.2007.15.3874

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  11 in total

1.  Chemotherapy use and risk of bone marrow suppression in a large population-based cohort of older women with breast and ovarian cancer.

Authors:  Zhannat Nurgalieva; Chih-Chin Liu; Xianglin L Du
Journal:  Med Oncol       Date:  2010-04-02       Impact factor: 3.064

Review 2.  When is high-dose intravenous iron repletion needed? Assessing new treatment options.

Authors:  David Gozzard
Journal:  Drug Des Devel Ther       Date:  2011-01-20       Impact factor: 4.162

3.  Preoperative anemia and surgical outcomes following laparotomy in a resource-limited setting.

Authors:  John Sincavage; Brittany Robinson; Vanessa J Msosa; Chawezi Katete; Laura N Purcell; Anthony Charles
Journal:  Am J Surg       Date:  2020-12-24       Impact factor: 3.125

4.  Anemia as a useful biomarker in patients with diffuse large B-cell lymphoma treated with R-CHOP immunochemotherapy.

Authors:  Junshik Hong; Hyun Seon Woo; Hyunchul Kim; Hee Kyung Ahn; Sun Jin Sym; Jinny Park; Jeong Yeal Ahn; Eun Kyung Cho; Dong Bok Shin; Jae Hoon Lee
Journal:  Cancer Sci       Date:  2014-11-05       Impact factor: 6.716

5.  Iron deficient erythropoiesis might play key role in development of anemia in cancer patients.

Authors:  Silvia Park; Chul Won Jung; Kihyun Kim; Seok Jin Kim; Won Seog Kim; Jun Ho Jang
Journal:  Oncotarget       Date:  2015-12-15

6.  Post-diagnosis hemoglobin change associates with overall survival of multiple malignancies - results from a 14-year hospital-based cohort of lung, breast, colorectal, and liver cancers.

Authors:  Shaogui Wan; Yinzhi Lai; Ronald E Myers; Bingshan Li; Juan P Palazzo; Ashlie L Burkart; Guokai Chen; Jinliang Xing; Hushan Yang
Journal:  BMC Cancer       Date:  2013-07-10       Impact factor: 4.430

Review 7.  Supportive care in hemato-oncology: a review in light of the latest guidelines.

Authors:  Eren Gündüz; Zafer Gülbaş
Journal:  Turk J Haematol       Date:  2012-03-05       Impact factor: 1.831

8.  Pre-treatment anemia is a poor prognostic factor in soft tissue sarcoma patients.

Authors:  Joanna Szkandera; Armin Gerger; Bernadette Liegl-Atzwanger; Michael Stotz; Hellmut Samonigg; Ferdinand Ploner; Tatjana Stojakovic; Andreas Leithner; Martin Pichler
Journal:  PLoS One       Date:  2014-09-10       Impact factor: 3.240

9.  Blood-Based Biomarkers Are Associated with Disease Recurrence and Survival in Gastrointestinal Stroma Tumor Patients after Surgical Resection.

Authors:  Michael Stotz; Bernadette Liegl-Atzwanger; Florian Posch; Edvin Mrsic; Michael Thalhammer; Tatjana Stojakovic; Angelika Bezan; Martin Pichler; Armin Gerger; Joanna Szkandera
Journal:  PLoS One       Date:  2016-07-25       Impact factor: 3.240

10.  Efficacy and safety of IV ferumoxytol for iron deficiency anemia in patients with cancer.

Authors:  Saroj Vadhan-Raj; Naomi V Dahl; Kristine Bernard; Zhu Li; William E Strauss
Journal:  J Blood Med       Date:  2017-12-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.